Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBX8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,987
Award facts
- Contract value 100% obligated
- $47,987.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $47,987 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 100 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 9, 2026, and was awarded on January 16, 2026. No set-aside designation was used in this competitive award. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy that positions the company as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a single-award prime vendor under the PPV-G GEN V contract, which carries a ceiling value of $499,999,999 and extends through December 31, 2036. The company's pharmaceutical product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables distributed to support recurring medical supply needs across the military healthcare system. With no subcontractor relationships identified and consistent delivery order performance across multiple therapeutic categories, DMS Pharmaceutical Group has established itself as a reliable supplier within the federal pharmaceutical supply chain serving the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FFBX8?
SPE2DR26FFBX8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FFBX8 worth?
The government has obligated $47,987 on SPE2DR26FFBX8.
Is contract SPE2DR26FFBX8 an order under another contract?
Yes. SPE2DR26FFBX8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBX8 competed?
The extent of competition for SPE2DR26FFBX8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award